Gold nanoparticles as novel agents for cancer therapy
- PMID: 22010024
- PMCID: PMC3473940
- DOI: 10.1259/bjr/59448833
Gold nanoparticles as novel agents for cancer therapy
Abstract
Gold nanoparticles are emerging as promising agents for cancer therapy and are being investigated as drug carriers, photothermal agents, contrast agents and radiosensitisers. This review introduces the field of nanotechnology with a focus on recent gold nanoparticle research which has led to early-phase clinical trials. In particular, the pre-clinical evidence for gold nanoparticles as sensitisers with ionising radiation in vitro and in vivo at kilovoltage and megavoltage energies is discussed.
Figures







References
-
- ASTM International E 2456-06 Terminology for nanotechnology. West Conshohocken, PA: ASTM International, 2006
-
- Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006;311:622–7 - PubMed
-
- Service RF. American Chemical Society meeting. Nanomaterials show signs of toxicity. Science 2003;300:243. - PubMed
-
- Magrez A, Kasas S, Salicio V, Pasquier N, Seo JW, Celio M, et al. Cellular toxicity of carbon-based nanomaterials. Nano Lett 2006;6:1121–5 - PubMed
-
- Chang E, Thekkek N, Yu WW, Colvin VL, Drezek R. Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small 2006;2:1412–17 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases